BioSpace Collaborative

Academic/Biomedical Research
News & Jobs
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

PROFILES
Company Profiles

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Research Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search
 Company Profile

 

Grupo Ferrer Internacional S.A. 

c/o Gran Via Carles III
94-98 Entresuelo
Barcelona    08028  Spain
Phone: 34-0-93-3306111 Fax: 34-0-93-4908933


SEARCH JOBS

View Clinical Trials from BioPharm Insight









 Company News
Alexza Pharmaceuticals, Inc. (ALXA) Announces Grupo Ferrer Internacional S.A.'s Launch Of ADASUVE® (Staccato® Loxapine) In Spain Triggering A $1 Million Milestone Payment 1/23/2014 9:21:33 AM    More...
Alexza Pharmaceuticals, Inc. (ALXA) and Grupo Ferrer Internacional S.A. Announce the Launch of ADASUVE® (Staccato® Loxapine) in Austria 10/24/2013 11:16:57 AM    More...
Grupo Ferrer Internacional S.A. Successfully Completes an Absorption, Tolerability and Safety Study in Juveniles as Young as Two Months of Age for Novel Antibacterial Compound Ozenoxacin 10/5/2012 11:00:15 AM    More...
Ferrer Submits IND for Arasertaconazole Nitrate, a Safe, Fast-Acting Topical Antifungal in Development for Vulvovaginal Candidiasis 8/8/2012 10:48:09 AM    More...
Alexza Pharmaceuticals, Inc. (ALXA) and Grupo Ferrer Internacional S.A. Amend Adasuve(TM) Partnership 3/8/2012 10:14:49 AM    More...
Alexza Pharmaceuticals, Inc. (ALXA) and Grupo Ferrer Internacional S.A. Establish $10 Million Partnership for the Commercialization of Adasuve(TM) (Staccato(R) Loxapine) in Europe and Latin America 10/6/2011 7:08:59 AM    More...
Vasogen (VSGN) and Grupo Ferrer Internacional S.A. Announce Initial Roll-out of Celacade 12/17/2007 7:58:49 AM    More...
Vasogen (VSGN) and Grupo Ferrer Internacional S.A. Form Collaboration to Commercialize Celacade(TM) in the European Union 4/18/2007 10:34:36 AM    More...
NicOx SA (NCOX.F) And Grupo Ferrer Internacional S.A. Select Candidate For Development In Dermatology Collaboration 5/16/2006 10:36:17 AM    More...
Barrier Therapeutics, Inc. (BTRX) Establishes European Commercialization Agreement Covering Four Products 10/19/2005 5:12:03 PM    More...
12